The Latest Breaking News on Pharma

The biotech sector is primed for robust expansion fueled by the growing needs for personalized medicines and favorable government initiatives. Amid this backdrop, investors could consider buying biotech stocks Esperion Therapeutics (ESPR), Corcept Therapeutics (CORT), and Shionogi (SGIOY). Keep reading.

The share price recovery has been partly driven by the surge in wholesale energy prices, which is beyond his control

Viking Therapeutics stock falls despite seemingly positive test results for a drug that treats a serious liver disease.

BridgeBio stock gave up gains midday Tuesday after releasing a Phase 2 study on a growth disorder treatment.

Urban and rural communities have come to depend on pharmacies as a trusted care option and a place for advice

Eli Lilly is in a buy zone, while weight-loss drug rival Novo Nordisk just forged a lower entry.

The FDA approved Moderna's RSV vaccine, allowing the biotech to launch its second-ever product. But Moderna stock retreated.

French pharmacists began their first walkout in 10 years on Thursday, closing up shop over drug shortages, low regulated prices, pharmacy closures and fears medications could be sold online.

Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."

AMD expands its private bug bounty program to the general public, allowing anyone who signs up for an Intigriti account to submit bugs and get paid.

Texas has tapped more than $45 million in federal funds to get the overdose-reversing drug into the hands of law enforcement, members of the public. But the program has been plagued by supply issues, delays and lack of communication.